April 15, 2013 / 1:34 PM / 4 years ago

CORRECTED-MARKET PULSE-MetroPCS, Life, Sprint, Citigroup, J.C. Penney

(Corrects Citigroup item to reflect the correct percentage figure)

April 15 (Reuters) - Some U.S. stocks to watch on Monday:

WALL ST TO OPEN LOWER AFTER CHINA, EMPIRE STATE DATA

U.S. stocks were poised for a lower open, putting the S&P 500 on track to dip for a second consecutive session after data showed growth in China and manufacturing growth in New York state were slower than expected. S&P 500 futures were down 5.8 points, the Dow Jones industrial average futures were down 35 points, and Nasdaq 100 futures were down 8.25 points.

** SPRINT-NEXTEL CORP, Friday close $6.22, up 16 pct premarket

** DISH NETWORK CORP, Friday close $37.63, down 2 pct premarket

** CLEARWIRE CORP, Friday close $3.26, up 1.5 pct premarket

Dish, the No. 2 U.S. satellite television provider, offered to buy Sprint for $25.5 billion in cash and stock, a move that could thwart the proposed acquisition of Sprint by Japan’s SoftBank Corp. Dish’s bid is the latest development in a shakeup of the U.S. wireless business, which is undergoing a wave of consolidation. Dish was already in amid an unsolicited offer for Clearwire, the wireless company majority owned by Sprint.

** CITIGROUP INC, Friday close $44.78, up 4 pct premarket

The bank reported a higher-than-expected 30 percent rise in first-quarter profit on Monday as revenue from its securities and investment banking business swelled.

** LIFE TECHNOLOGIES CORP, Friday close $68.00, up 8 pct premarket

** THERMO FISHER SCIENTIFIC INC, Friday close $79.59, up 0.5 pct premarket

The genetic testing equipment maker has agreed to a $13.6 billion cash buyout by Thermo Fisher, in one of the year’s biggest corporate takeovers. The acquisition values Life Technologies at $76 per share and would catapult Thermo Fisher into the hot field of genetic sequencing where researchers, drugmakers and doctors are uncovering the genetic factors underpinning diseases to better tailor treatments to the patients.

** NEWMONT MINING CORP, Friday close $36.37, down 5 pct premarket

** FREEPORT-MCMORAN COPPER & GOLD INC, Friday close $31.92, down 6 pct premarket

** BARRICK GOLD CORP , Friday close $22.62, down 4.5 pct premarket

** YAMANA GOLD INC , Friday close $13.09, down 8 pct premarket

** GOLDCORP INC , Friday close $29.68, down 5 pct premarket

Gold dropped as much as 6.3 percent on Monday to below $1,400 per ounce for the first time since March 2011, dragging down stocks of the gold producers. Investors ditched gold along with other commodities from oil to copper after a less-than-forecast growth in China’s gross domestic product in the first quarter stoked doubts about the health of the global economy. Spot gold dropped as low as $1,384.69 an ounce and was at $1,409.26 by 1048 GMT, still down 4.7 percent.

** IAMGOLD CORP , Friday close $5.77, down 8 pct premarket

Canadian gold miner Iamgold Corp said the Suriname parliament on Saturday approved the agreement that the company signed last November with the South American country’s government to expand its Rosebel mine.

** COEUR D‘ALENE MINES CORP, Friday close $16.65, down 7 pct premarket

The largest U.S.-based silver miner reported a 22 percent drop in first-quarter silver production due to lower grade ore processed at its Palmarejo mine in Mexico. Coeur D‘Alene produced 3.8 million ounces silver in the quarter. Average realized price was $30.61 per ounce.

** THERAVANCE INC, Friday close $23.76, up 5 pct premarket

Reviewers for the U.S. Food and Drug Administration said on Monday that the efficacy data for GlaxoSmithKline Plc and Theravance’s experimental drug to treat chronic obstructive pulmonary disease are not entirely consistent.

** METROPCS COMMUNICATIONS, Friday close $11.52, down 3.2 pct premarket

The company amended the terms for its proposed merger with Deutsche Telekom unit T-Mobile USA, and asked shareholders to vote for the deal.

The move follows Deutsche Telekom sweetening its offer last Wednesday, bowing to pressure from activists and proxy advisory firms.

** BIOCRYST PHARMACEUTICALS INC, Friday close $1.89, up 165 pct premarket

** SINOVAC BIOTECH LTD, Friday close $3.85, up 12 pct premarket

** NOVAVAX INC, Friday close $2.57, up 5 pct premarket

Shares of companies that are developing anti-viral agents to counter the avian influenza virus rose after China said the death toll from a new strain of bird flu rose to 13.

** ACORDA THERAPEUTICS INC, Friday close $31.52, up 8.6 pct premarket

The pharmaceutical company said results of a mid-stage study testing a 10 mg dose of its multiple sclerosis drug Ampyra showed improved walking ability in people who suffered a stroke. This study included 83 participants who experienced a stroke due to blood clots at least six months prior to enrollment and had chronic problems in movements.

** DISCOVERY LABORATORIES INC, Friday close $2.39, down 6 pct premarket

The biotechnology company said the U.S. health regulator asked for clarifications on the updated product specifications submitted by the company on its respiratory drug, Surfaxin. Discovery said it will provide a response within two months and expects to launch the drug in the fourth quarter of 2013.

Discovery said in October that its analysis of Surfaxin showed product specifications needed to be updated.

** NATIONAL FINANCIAL PARTNERS, Friday close $23.41, up 6 pct premarket

The wealth management company said it agreed to be bought by private equity investment firm Madison Dearborn Partners LLC for about $1.3 billion, including debt.

** MECHEL OAO , Friday close $4.30, down 9 pct premarket

The heavily indebted Russian miner reported bigger than expected fourth-quarter losses due to weak demand on Monday, sending its share price to a record low.

** GEVO INC, Friday close $2.09, up 3.5 pct after market

The biofuel company filed for a mixed shelf offering of a combination of its common stock, preferred stock or debt of up to $250 million, according to a regulatory filing on Friday. (r.reuters.com/dud47t)

** J.C. PENNEY CO INC, Friday close $14.62, down 1.5 pct premarket

The department store operator said on Monday that it had drawn $850 million out of a $1.85 billion revolving credit facility to help buy inventory as it moves past a failed turnaround. The company also said it will continue to explore additional capital-raising alternatives with the help of its financial advisers.

** JPMORGAN CHASE & CO, Friday close $49.01, down 0.2 pct premarket

The company should split the roles of chairman and chief executive officer to restore credibility with regulators and manage the bank more effectively, a group of investors said in a letter to other shareholders on Monday.

** BIOCRYST PHARMACEUTICALS INC, Friday close $1.89, up 165 pct premarket

Shares of the company, which is developing an intravenous anti-viral agent to treat the influenza virus, continued their rise as the number of people infected by bird flu in China rose further. The death toll rose to 13 on Sunday.

** CHARLES SCHWAB CORP, Friday close $17.28

The online broker reported a 6 percent increase in quarterly profit, but said low rates and relatively muted trading activity continued to weigh on its results.

** AMAZON.COM INC, Friday close $272.87, down 0.4 pct premarket

The world’s largest Internet retailer increased stock compensation for key executives in 2012, according to a regulatory filing on Friday, in which Amazon added Apple Inc to the peer group it uses to help determine how much to pay executives.

** GOLDMAN SACHS GROUP INC, Friday close $149.12, up 0.3 pct premarket

The company’s board awarded Chief Executive Lloyd Blankfein a 75 percent increase in compensation, to $21 million, for 2012 - including pay, bonus and restricted stock award.

** M&T BANK CORP, Friday close $100.24

** HUDSON CITY BANCORP INC, Friday close $8.29

M&T Bank’s proposed purchase of Hudson City Bancorp will probably take more time to close than previously expected because of U.S. regulatory concerns over anti-money-laundering procedures, the banks said on Friday. (Compiled by Aditi Shrivastava; Editing by Joyjeet Das)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below